p21 Is a Critical CDK2 Regulator Essential for Proliferation Control in Rb-deficient Cells

by Brugarolas, James, Bronson, Roderick T., Jacks, Tyler
Published 1998

Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome

by Denard, Bray, Pavia-Jimenez, Andrea, Chen, Weina, Williams, Noelle S., Naina, Harris, Collins, Robert, Brugarolas, James, Ye, Jin
Published 2015

Regulation of TFEB and V-ATPases by mTORC1

by Peña-Llopis, Samuel, Vega-Rubin-de-Celis, Silvia, Schwartz, Jacob C, Wolff, Nicholas C, Tran, Tram Anh T, Zou, Lihua, Xie, Xian-Jin, Corey, David R, Brugarolas, James
Published 2011

Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes

by Hasan, Maroof, Koch, James, Rakheja, Dinesh, Pattnaik, Asit K., Brugarolas, James, Dozmorov, Igor, Levine, Beth, Wakeland, Edward K., Lee-kirsch, Min Ae, Yan, Nan
Published 2012

Multi-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 year experience and lessons learned

by Gayed, Bishoy A., Youssef, Ramy, Darwish, Oussama, Kapur, Payal, Bagrodia, Aditya, Brugarolas, James, Raj, Ganesh, DiMaio, J. Michael, Sagalowsky, Arthur, Margulis, Vitaly
Published 2016

Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma

by Gayed, Bishoy A, Gillen, Jessica, Christie, Alana, Peña-Llopis, Samuel, Xie, Xian-Jin, Yan, Jingsheng, Karam, Jose A, Raj, Ganesh, Sagalowsky, Arthur I, Lotan, Yair, Margulis, Vitaly, Brugarolas, James
Published 2015

High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma

by Wolff, Nicholas C., Pavía-Jiménez, Andrea, Tcheuyap, Vanina T., Alexander, Shane, Vishwanath, Mridula, Christie, Alana, Xie, Xian-Jin, Williams, Noelle S., Kapur, Payal, Posner, Bruce, McKay, Renée M., Brugarolas, James
Published 2015

Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death

by Ho, Thai H., Kapur, Payal, Joseph, Richard W., Serie, Daniel J., Eckel-Passow, Jeanette E., Tong, Pan, Wang, Jing, Castle, Erik P., Stanton, Melissa L., Cheville, John C., Jonasch, Eric, Brugarolas, James, Parker, Alexander S.
Published 2015

BAP1 loss defines a new class of renal cell carcinoma

by Peña-Llopis, Samuel, Vega-Rubín-de-Celis, Silvia, Liao, Arnold, Leng, Nan, Pavía-Jiménez, Andrea, Wang, Shanshan, Yamasaki, Toshinari, Zhrebker, Leah, Sivanand, Sharanya, Spence, Patrick, Kinch, Lisa, Hambuch, Tina, Jain, Suneer, Lotan, Yair, Margulis, Vitaly, Sagalowsky, Arthur I., Summerour, Pia Banerji, Kabbani, Wareef, Wong, S. W. Wendy, Grishin, Nick, Laurent, Marc, Xie, Xian-Jin, Haudenschild, Christian D., Ross, Mark T., Bentley, David R., Kapur, Payal, Brugarolas, James
Published 2012